Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Nu.Q® Vet Cancer Test: How to submit a sample

Tuesday, April 1, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The article discusses the Nu.Q® Vet Cancer Test, detailing how to submit samples through a reference laboratory and at the point of care using the Element i+. Additionally, it highlights the upcoming publication of a study on the test in cats, which could unlock a $5 million milestone payment for Volition.
Price reaction · baseline $11.402 (2025-03-31 close) · hit pre-market · 3 other VNRX headline(s) in the window, move may be shared
day 0 close · peak
-9%
day 1
-5.2%
day 3
-6.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • Introduction of the Nu.Q® Vet Cancer Test is a significant advancement.
  • The automated testing process with Fujifilm Vet Systems enhances accessibility.
  • Potential for a $5 million milestone payment indicates strong investor interest.

Full Press Release Details

Nu.Q® Vet Cancer Test: how to submit a sample through a reference laboratory
Nu.Q® Vet Cancer Test: how to submit a sample at the point of care using the Element i+

Related Articles

• Press Releases Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment
• Press Releases Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment

Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

How can I submit a sample for the Nu.Q® Vet Cancer Test?

Samples can be submitted through a reference laboratory or at the point of care using the Element i+.

What is the significance of the upcoming study publication?

The publication is expected to unlock a $5 million contractual milestone payment for Volition.

What company is involved with the Nu.Q® Vet Cancer Test?

Volition is the company behind the Nu.Q® Vet Cancer Test and its automated processes.

What advancements are mentioned in the article?

The article highlights the first automated Nu.Q® Vet Cancer Test in collaboration with Fujifilm Vet Systems.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare Nu.Q® cancer test sample submission Fujifilm Vet Systems
Last updated: Apr 1, 2025

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk